Stay informed with the latest updates for the inheritable blood disorders community.

NBDF & Community
First Patient Dosed in Freeline’s Dose-Confirmation Trial for Hemophilia B Gene Therapy
Meet JGP Fellow, Dr. Vishal Srivastava!
NBDF & Community
BioMarin Provides Update Including Next Steps for Investigational Gene Therapy
Meet Former JGP Fellow, Dr. Elizabeth Chappell, MBA!
NBDF & Community
Former JGP Fellow, Dr. Mettine H.A. Bos
Meet Former JGP Fellow, Dr. Mettine H.A. Bos!
NBDF & Community
Meet Former JGP Fellow, Dr. Hongxia Fu!
Industry
BioMarin Shares Community Update for Valoctocogene Roxaparvovec
BioMarin Shares Community Update for Valoctocogene Roxaparvovec
Press Releases
Red Tie Soiree 2022
Annual Red Tie Soiree Heads to San Francisco This Fall
NBDF & Community
NHF Employee Highlight - Meet Michelle Witkop!
Industry
Clinical Trial Gene Therapy Double Helix
Recruitment Reopened for Phase 3 AFFINE Gene Therapy Trial
Press Releases
Watch the Wednesday Webinar Series
NHF Announces Fall 2022 Wednesday Webinar Schedule
NBDF & Community
Patti Williford
Meet Former NYLI Member, Patti Williford!
NBDF & Community
Joseph Mah
Meet Former NYLI Member, Joseph Mah!
NBDF & Community
Former NYLI member Dejah Smith
Meet Former NYLI Member, Dejah Smith!
NBDF & Community
gavel stethoscope and caduceus sign on books background medicine picture
Message from NHF CEO Len Valentino
Medical
Clinical Trial Gene Double Helix
Update for the Hemophilia Community
Medical
Person interacting with computer and taking notes
Virtual Grand Round Series to Focus on Hemophilia Gene Therapy